APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor 7

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Metabotropic Glutamate Receptor 7 Industry Growth and Trends Forecast to 2032

19 December 202572 pages

Choose your research edition.

Industry ResearchMetabotropic Glutamate Receptor 7 Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabotropic Glutamate Receptor 7 Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Metabotropic Glutamate Receptor 7 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabotropic Glutamate Receptor 7 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabotropic Glutamate Receptor 7 Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Metabotropic Glutamate Receptor 7 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Metabotropic Glutamate Receptor 7 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Metabotropic Glutamate Receptor 7 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metabotropic Glutamate Receptor 7 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metabotropic Glutamate Receptor 7 include Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bio-Pharm Solutions Co Ltd and Pragma Therapeutics SAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Metabotropic Glutamate Receptor 7 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Metabotropic Glutamate Receptor 7 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metabotropic Glutamate Receptor 7 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metabotropic Glutamate Receptor 7.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Metabotropic Glutamate Receptor 7 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Metabotropic Glutamate Receptor 7 Market by Company

Addex Therapeutics Ltd

Aevi Genomic Medicine Inc

Bio-Pharm Solutions Co Ltd

Pragma Therapeutics SAS

Metabotropic Glutamate Receptor 7 Segment by Type

PGT-117

JBPOS-0101

ADX-71743

Others

Metabotropic Glutamate Receptor 7 Segment by Application

Infantile Spasm

Generalized Anxiety Disorder

Status Epilepticus

Others

Metabotropic Glutamate Receptor 7 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor 7 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor 7 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor 7.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metabotropic Glutamate Receptor 7 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Metabotropic Glutamate Receptor 7 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PGT-117 Table 2. Major Company of JBPOS-0101 Table 3. Major Company of ADX-71743 Table 4. Major Company of Others Table 5. Global Metabotropic Glutamate Receptor 7 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 7. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Type (2021-2026) Table 8. Global Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (US$ Million) Table 9. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Type (2021-2026) Table 10. Global Metabotropic Glutamate Receptor 7 Price by Type (2021-2026) & (US$/Unit) Table 11. Global Metabotropic Glutamate Receptor 7 Sales by Type (2027-2032) & (W Units) Table 12. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Type (2027-2032) Table 13. Global Metabotropic Glutamate Receptor 7 Sales by Type (2027-2032) & (US$ Million) Table 14. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Type (2027-2032) Table 15. Global Metabotropic Glutamate Receptor 7 Price by Type (2027-2032) & (US$/Unit) Table 16. North America Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 17. North America Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 19. Europe Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 23. Latin America Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Type (2021-2026) & (US$ Million) Table 26. Metabotropic Glutamate Receptor 7 Industry Trends Table 27. Metabotropic Glutamate Receptor 7 Industry Drivers Table 28. Metabotropic Glutamate Receptor 7 Industry Opportunities and Challenges Table 29. Metabotropic Glutamate Receptor 7 Industry Restraints Table 30. Global Metabotropic Glutamate Receptor 7 Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Company (2021-2026) Table 32. Global Metabotropic Glutamate Receptor 7 Sales by Company (2021-2026) & (W Units) Table 33. Global Metabotropic Glutamate Receptor 7 Sales Share by Company (2021-2026) Table 34. Global Metabotropic Glutamate Receptor 7 Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Metabotropic Glutamate Receptor 7 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Metabotropic Glutamate Receptor 7 Major Company Production Sites and Headquarters Table 37. Global Metabotropic Glutamate Receptor 7 Company, Product Type & Application Table 38. Global Metabotropic Glutamate Receptor 7 Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Metabotropic Glutamate Receptor 7 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Metabotropic Glutamate Receptor 7 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Metabotropic Glutamate Receptor 7 Sales by Region (2021-2026) & (W Units) Table 43. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Region (2021-2026) Table 44. Global Metabotropic Glutamate Receptor 7 Sales by Region (2021-2026) & (US$ Million) Table 45. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Region (2021-2026) Table 46. Global Metabotropic Glutamate Receptor 7 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Metabotropic Glutamate Receptor 7 Sales by Region (2027-2032) & (W Units) Table 48. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Region (2027-2032) Table 49. Global Metabotropic Glutamate Receptor 7 Sales by Region (2027-2032) & (US$ Million) Table 50. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Region (2027-2032) Table 51. Global Metabotropic Glutamate Receptor 7 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Metabotropic Glutamate Receptor 7 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 54. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Application (2021-2026) Table 55. Global Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (US$ Million) Table 56. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Application (2021-2026) Table 57. Global Metabotropic Glutamate Receptor 7 Price by Application (2021-2026) & (US$/Unit) Table 58. Global Metabotropic Glutamate Receptor 7 Sales by Application (2027-2032) & (W Units) Table 59. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Application (2027-2032) Table 60. Global Metabotropic Glutamate Receptor 7 Sales by Application (2027-2032) & (US$ Million) Table 61. Global Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Application (2027-2032) Table 62. Global Metabotropic Glutamate Receptor 7 Price by Application (2027-2032) & (US$/Unit) Table 63. North America Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 64. North America Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 66. Europe Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 70. Latin America Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Application (2021-2026) & (US$ Million) Table 73. Addex Therapeutics Ltd Company Information Table 74. Addex Therapeutics Ltd Business Overview Table 75. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Product Portfolio Table 77. Addex Therapeutics Ltd Recent Development Table 78. Aevi Genomic Medicine Inc Company Information Table 79. Aevi Genomic Medicine Inc Business Overview Table 80. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Product Portfolio Table 82. Aevi Genomic Medicine Inc Recent Development Table 83. Bio-Pharm Solutions Co Ltd Company Information Table 84. Bio-Pharm Solutions Co Ltd Business Overview Table 85. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Product Portfolio Table 87. Bio-Pharm Solutions Co Ltd Recent Development Table 88. Pragma Therapeutics SAS Company Information Table 89. Pragma Therapeutics SAS Business Overview Table 90. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Product Portfolio Table 92. Pragma Therapeutics SAS Recent Development Table 93. North America Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 94. North America Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026) & (W Units) Table 95. North America Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2021-2026) Table 96. North America Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2027-2032) & (W Units) Table 97. North America Metabotropic Glutamate Receptor 7 Sales Market Share Forecast by Country (2027-2032) Table 98. North America Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Metabotropic Glutamate Receptor 7 Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Metabotropic Glutamate Receptor 7 Market Share by Country (2021-2026) Table 101. North America Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Metabotropic Glutamate Receptor 7 Market Share Forecast by Country (2027-2032) Table 103. Europe Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 104. Europe Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026) & (W Units) Table 105. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2021-2026) Table 106. Europe Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2027-2032) & (W Units) Table 107. Europe Metabotropic Glutamate Receptor 7 Sales Market Share Forecast by Country (2027-2032) Table 108. Europe Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Metabotropic Glutamate Receptor 7 Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Metabotropic Glutamate Receptor 7 Market Share by Country (2021-2026) Table 111. Europe Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Metabotropic Glutamate Receptor 7 Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026) & (W Units) Table 115. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2021-2026) Table 116. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2027-2032) & (W Units) Table 117. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Metabotropic Glutamate Receptor 7 Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Metabotropic Glutamate Receptor 7 Market Share by Country (2021-2026) Table 121. Asia-Pacific Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Metabotropic Glutamate Receptor 7 Market Share Forecast by Country (2027-2032) Table 123. Latin America Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 124. Latin America Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026) & (W Units) Table 125. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2021-2026) Table 126. Latin America Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2027-2032) & (W Units) Table 127. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share Forecast by Country (2027-2032) Table 128. Latin America Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Metabotropic Glutamate Receptor 7 Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Metabotropic Glutamate Receptor 7 Market Share by Country (2021-2026) Table 131. Latin America Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Metabotropic Glutamate Receptor 7 Market Share Forecast by Country (2027-2032) Table 133. Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 134. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026) & (W Units) Table 135. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2021-2026) Table 136. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2027-2032) & (W Units) Table 137. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East and Africa Metabotropic Glutamate Receptor 7 Market Share by Country (2021-2026) Table 141. Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Metabotropic Glutamate Receptor 7 Market Share Forecast by Country (2027-2032) Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Metabotropic Glutamate Receptor 7 Distributors List Table 146. Metabotropic Glutamate Receptor 7 Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Metabotropic Glutamate Receptor 7 Image Figure 2. Global Metabotropic Glutamate Receptor 7 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metabotropic Glutamate Receptor 7 Market Size (2021-2032) & (US$ Million) Figure 4. Global Metabotropic Glutamate Receptor 7 Sales (2021-2032) & (W Units) Figure 5. PGT-117 Image Figure 6. Global PGT-117 Sales YoY Growth (2021-2032) & (W Units) Figure 7. JBPOS-0101 Image Figure 8. Global JBPOS-0101 Sales YoY Growth (2021-2032) & (W Units) Figure 9. ADX-71743 Image Figure 10. Global ADX-71743 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Metabotropic Glutamate Receptor 7 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Metabotropic Glutamate Receptor 7 Market Share by Type 2025 VS 2032 Figure 15. North America Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Type in 2025 Figure 16. North America Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Type in 2025 Figure 17. Europe Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Type in 2025 Figure 18. Europe Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Type in 2025 Figure 21. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Metabotropic Glutamate Receptor 7 Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Infantile Spasm Image Figure 28. Global Infantile Spasm Sales YoY Growth (2021-2032) & (W Units) Figure 29. Generalized Anxiety Disorder Image Figure 30. Global Generalized Anxiety Disorder Sales YoY Growth (2021-2032) & (W Units) Figure 31. Status Epilepticus Image Figure 32. Global Status Epilepticus Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Metabotropic Glutamate Receptor 7 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Metabotropic Glutamate Receptor 7 Market Share by Application 2025 VS 2032 Figure 37. North America Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Application in 2025 Figure 38. North America Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Application in 2025 Figure 39. Europe Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Application in 2025 Figure 40. Europe Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Application in 2025 Figure 43. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share in Value by Application in 2025 Figure 47. North America Metabotropic Glutamate Receptor 7 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Metabotropic Glutamate Receptor 7 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Metabotropic Glutamate Receptor 7 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Metabotropic Glutamate Receptor 7 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Metabotropic Glutamate Receptor 7 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Metabotropic Glutamate Receptor 7 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Metabotropic Glutamate Receptor 7 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Metabotropic Glutamate Receptor 7 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Metabotropic Glutamate Receptor 7 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Metabotropic Glutamate Receptor 7 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Metabotropic Glutamate Receptor 7 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Metabotropic Glutamate Receptor 7 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Metabotropic Glutamate Receptor 7 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Metabotropic Glutamate Receptor 7 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Metabotropic Glutamate Receptor 7 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Metabotropic Glutamate Receptor 7 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Metabotropic Glutamate Receptor 7 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • PGT-117
  • JBPOS-0101
  • ADX-71743
  • Others
Applications
  • Infantile Spasm
  • Generalized Anxiety Disorder
  • Status Epilepticus
  • Others
Companies covered
  • Addex Therapeutics Ltd
  • Aevi Genomic Medicine Inc
  • Bio-Pharm Solutions Co Ltd
  • Pragma Therapeutics SAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Metabotropic Glutamate Receptor 7 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Metabotropic Glutamate Receptor 7 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Metabotropic Glutamate Receptor 7 Market by Type
  6. 1.3.1 PGT-117
  7. 1.3.2 JBPOS-0101
  8. 1.3.3 ADX-71743
  9. 1.3.4 Others
  10. 1.4 Global Metabotropic Glutamate Receptor 7 Market Size by Type
  11. 1.4.1 Global Metabotropic Glutamate Receptor 7 Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Metabotropic Glutamate Receptor 7 Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Metabotropic Glutamate Receptor 7 Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Metabotropic Glutamate Receptor 7 Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Metabotropic Glutamate Receptor 7 Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Metabotropic Glutamate Receptor 7 Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Metabotropic Glutamate Receptor 7 Industry Trends
  2. 2.2 Metabotropic Glutamate Receptor 7 Industry Drivers
  3. 2.3 Metabotropic Glutamate Receptor 7 Industry Opportunities and Challenges
  4. 2.4 Metabotropic Glutamate Receptor 7 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Metabotropic Glutamate Receptor 7 Revenue (2021-2026)
  2. 3.2 Global Top Players by Metabotropic Glutamate Receptor 7 Sales (2021-2026)
  3. 3.3 Global Top Players by Metabotropic Glutamate Receptor 7 Price (2021-2026)
  4. 3.4 Global Metabotropic Glutamate Receptor 7 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metabotropic Glutamate Receptor 7 Major Company Production Sites & Headquarters
  6. 3.6 Global Metabotropic Glutamate Receptor 7 Company, Product Type & Application
  7. 3.7 Global Metabotropic Glutamate Receptor 7 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metabotropic Glutamate Receptor 7 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metabotropic Glutamate Receptor 7 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metabotropic Glutamate Receptor 7 Tier 1, Tier 2, and Tier 3
4 Metabotropic Glutamate Receptor 7 Regional Status and Outlook
  1. 4.1 Global Metabotropic Glutamate Receptor 7 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Metabotropic Glutamate Receptor 7 Historic Market Size by Region
  3. 4.2.1 Global Metabotropic Glutamate Receptor 7 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Metabotropic Glutamate Receptor 7 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Metabotropic Glutamate Receptor 7 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Metabotropic Glutamate Receptor 7 Forecasted Market Size by Region
  7. 4.3.1 Global Metabotropic Glutamate Receptor 7 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Metabotropic Glutamate Receptor 7 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Metabotropic Glutamate Receptor 7 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metabotropic Glutamate Receptor 7 by Application
  1. 5.1 Metabotropic Glutamate Receptor 7 Market by Application
  2. 5.1.1 Infantile Spasm
  3. 5.1.2 Generalized Anxiety Disorder
  4. 5.1.3 Status Epilepticus
  5. 5.1.4 Others
  6. 5.2 Global Metabotropic Glutamate Receptor 7 Market Size by Application
  7. 5.2.1 Global Metabotropic Glutamate Receptor 7 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Metabotropic Glutamate Receptor 7 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Metabotropic Glutamate Receptor 7 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Metabotropic Glutamate Receptor 7 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Metabotropic Glutamate Receptor 7 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Metabotropic Glutamate Receptor 7 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Addex Therapeutics Ltd
  2. 6.1.1 Addex Therapeutics Ltd Company Information
  3. 6.1.2 Addex Therapeutics Ltd Business Overview
  4. 6.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Product Portfolio
  6. 6.1.5 Addex Therapeutics Ltd Recent Developments
  7. 6.2 Aevi Genomic Medicine Inc
  8. 6.2.1 Aevi Genomic Medicine Inc Company Information
  9. 6.2.2 Aevi Genomic Medicine Inc Business Overview
  10. 6.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Product Portfolio
  12. 6.2.5 Aevi Genomic Medicine Inc Recent Developments
  13. 6.3 Bio-Pharm Solutions Co Ltd
  14. 6.3.1 Bio-Pharm Solutions Co Ltd Company Information
  15. 6.3.2 Bio-Pharm Solutions Co Ltd Business Overview
  16. 6.3.3 Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Product Portfolio
  18. 6.3.5 Bio-Pharm Solutions Co Ltd Recent Developments
  19. 6.4 Pragma Therapeutics SAS
  20. 6.4.1 Pragma Therapeutics SAS Company Information
  21. 6.4.2 Pragma Therapeutics SAS Business Overview
  22. 6.4.3 Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Product Portfolio
  24. 6.4.5 Pragma Therapeutics SAS Recent Developments
7 North America by Country
  1. 7.1 North America Metabotropic Glutamate Receptor 7 Sales by Country
  2. 7.1.1 North America Metabotropic Glutamate Receptor 7 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026)
  4. 7.1.3 North America Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Metabotropic Glutamate Receptor 7 Market Size by Country
  6. 7.2.1 North America Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Metabotropic Glutamate Receptor 7 Market Size by Country (2021-2026)
  8. 7.2.3 North America Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Metabotropic Glutamate Receptor 7 Sales by Country
  2. 8.1.1 Europe Metabotropic Glutamate Receptor 7 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026)
  4. 8.1.3 Europe Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Metabotropic Glutamate Receptor 7 Market Size by Country
  6. 8.2.1 Europe Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Metabotropic Glutamate Receptor 7 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Metabotropic Glutamate Receptor 7 Sales by Country
  2. 9.1.1 Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Metabotropic Glutamate Receptor 7 Market Size by Country
  6. 9.2.1 Asia-Pacific Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Metabotropic Glutamate Receptor 7 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Metabotropic Glutamate Receptor 7 Sales by Country
  2. 10.1.1 South America Metabotropic Glutamate Receptor 7 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026)
  4. 10.1.3 South America Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Metabotropic Glutamate Receptor 7 Market Size by Country
  6. 10.2.1 South America Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Metabotropic Glutamate Receptor 7 Market Size by Country (2021-2026)
  8. 10.2.3 South America Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Country
  2. 11.1.1 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size by Country
  6. 11.2.1 Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Metabotropic Glutamate Receptor 7 Value Chain Analysis
  2. 12.1.1 Metabotropic Glutamate Receptor 7 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Metabotropic Glutamate Receptor 7 Production Mode & Process
  7. 12.2 Metabotropic Glutamate Receptor 7 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Metabotropic Glutamate Receptor 7 Distributors
  10. 12.2.3 Metabotropic Glutamate Receptor 7 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst